My opinions with respect to only to the company BioElectronics and its stock, 'BIEL' are these:
It's a thinly held, tiny, US developmental company, with no money to spare and appropriately requires FDA regulatory approval for ActiPatch, its patented lead product. FDA has come a long way with its Proposed Rule and is drafting its Final Rule to reclassify such devices Class II from Class III. BIEL and others in the SWT and PEMF space will apply for OTC approval, but BIEL is THE leader in the pain space with its patented, miniaturized pain devices.
ActiPatch works and is totally side-effect free. Many studies exist for the reading by those who wish to do so. I believe ALLAY, for menstrual cramping and pain for tens of millions of American women suffering from these every month of their lives is a huge sleeper. No drugs, dealing with pain, side-effect free, inexpensive. These devices are already a disruptive technology!
Shareholders have had to be extremely patient with the growing pains of the little engine that could. Common sense tells me the market cap must and will rise substantially on the publishing of the Final Order for reclassification. What I do know is the market cap will be a substantial multiple of where it is now with ActiPatch as a Class II device for a host of indications. What will it rise to? Who knows.
The company has progressed very well in the UK, proven by amazing sales results. It is moving forward in Canada, with possible upcoming news about Costco and Walmart in Canada, after several false starts up there, and still sits in neutral here at home where it cannot legally market and sell its products, yet.
But, by everything I see, the tsunami is coming. What share price? 4 to 8 cents initially, then a drop, then 10 to 15 cents when OTC becomes a reality. What is that based on? Speculation of what I see as future reality on sales potential and market cap. No factoring in of market nuances and greed. Why am I confident? Honest, solid information and correspondence.
The product worked well for me on a serious sports injury, I bought stock in 2009 and did very, very well. I watched it implode because of a few poor management decisions and treachery by some scoundrels, both years ago. I observed as senior management threw the scoundrels out. The company has fought its way back, learned the regulatory game and stayed alive, declaring that it was selling stock to finance its survival.
FDA took charge as it should have by hiring new people as it said it would. Then came the UK, Boots, FDA Proposed Order, Walgreens bought Boots, Kotack appointed, 510(k) application submitted this year as invited by FDA, competent law firm, UofM bioengineering students breakthrough study on PEMF treatment of bone fractures. Credit to Andy Whelan, an ex-US Marine, with a streak of stubborn Irish, just wouldn't quit. Nice story? Yup, this is America and there have been too many advances to list here. The tsunami is coming.
When will it happen? Soon, remember where you heard it. And then I will be able to walk into any Walgreens and buy an ActiPatch because that is how things should be for the American people, for all the right reasons. It's not who is right, it's what is right and buying ActiPatch OTC when I want to is right. England and Canada are ahead of us on this one, but so what, we'll get 'er done.
Greetings to the Good Guys (and Gals) yamayama
